- Home
- IMRX vs VANI Comparison
IMRX vs VANI Comparison
Compare IMRX & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- VANI
- Stock Information
- Founded
- IMRX 2008
- VANI 1998
- Country
- IMRX United States
- VANI United States
- Employees
- IMRX N/A
- VANI N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IMRX Health Care
- VANI Health Care
- Exchange
- IMRX Nasdaq
- VANI Nasdaq
- Market Cap
- IMRX 62.7M
- VANI 65.2M
- IPO Year
- IMRX 2021
- VANI 2014
- Fundamental
- Price
- IMRX $1.64
- VANI $1.11
- Analyst Decision
- IMRX Strong Buy
- VANI Strong Buy
- Analyst Count
- IMRX 3
- VANI 1
- Target Price
- IMRX $11.00
- VANI $4.00
- AVG Volume (30 Days)
- IMRX 192.2K
- VANI 102.0K
- Earning Date
- IMRX 03-20-2025
- VANI 05-12-2025
- Dividend Yield
- IMRX N/A
- VANI N/A
- EPS Growth
- IMRX N/A
- VANI N/A
- EPS
- IMRX N/A
- VANI N/A
- Revenue
- IMRX N/A
- VANI N/A
- Revenue This Year
- IMRX N/A
- VANI N/A
- Revenue Next Year
- IMRX N/A
- VANI N/A
- P/E Ratio
- IMRX N/A
- VANI N/A
- Revenue Growth
- IMRX N/A
- VANI N/A
- 52 Week Low
- IMRX $1.00
- VANI $1.03
- 52 Week High
- IMRX $3.83
- VANI $2.22
- Technical
- Relative Strength Index (RSI)
- IMRX 46.94
- VANI 49.81
- Support Level
- IMRX $1.60
- VANI $1.06
- Resistance Level
- IMRX $1.91
- VANI $1.16
- Average True Range (ATR)
- IMRX 0.11
- VANI 0.04
- MACD
- IMRX 0.02
- VANI 0.01
- Stochastic Oscillator
- IMRX 44.90
- VANI 61.54
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.